Introduction
============

Nonalcoholic fatty liver disease is a type of common chronic liver disease, with a gradually increasing number of cases in China. This disease threatens people\'s physical and mental health ([@b1-etm-0-0-5490]). The pathogenesis of nonalcoholic fatty liver disease remains unclear, and most studies suggest that ([@b2-etm-0-0-5490]--[@b4-etm-0-0-5490]) this disease may be closely related to many factors such as abnormal lipid metabolism and an inflammatory response. Nonalcoholic steatohepatitis is an important stage during the development and progression of nonalcoholic fatty liver disease. In recent years, many studies have demonstrated that the imbalance of intestinal flora in the body leads to obesity, which is closely related to nonalcoholic steatohepatitis ([@b5-etm-0-0-5490]). Interleukin-10 (IL-10) and IL-17 are relatively common pro-inflammatory factors. Currently, there are few studies on the correlation between changes in intestinal flora and the inflammatory factors IL-10 and IL-17 in patients with nonalcoholic steatohepatitis. Here we analyzed the correlation between changes in intestinal flora and IL-10 and IL-17 in order to reveal the pathogenesis of nonalcoholic fatty liver disease.

Patients and methods
====================

### General data

Ninety patients that were diagnosed with nonalcoholic steatohepatitis and treated at Xuzhou Infectious Disease Hospital from February 2016 to February 2017 were selected as the patient group. Their diagnosis conformed to the diagnostic criteria in Diagnosis and Treatment Guidance on Nonalcoholic Fatty Liver Disease ([@b6-etm-0-0-5490]). Patients with viral or autoimmune liver disease, pregnant or lactating patients, and patients with prior use of medicine that would affect the intestinal flora in the body in the prior 15 days were eliminated. In the patient group, there were 50 males and 40 females aged 25--66 years with an average age of 45.7±1.5 years. In the control group, there were 80 healthy people without intestinal, hepatic and biliary diseases who were undergoing physical examination in the hospital during the same time period and were selected as the control group, including 38 males and 32 females aged 24--65 years with an average age of 45.2±1.3 years. All the patients and/or guardians signed the informed consent. The study was approved by the Ethics Committee of Xuzhou Infectious Disease Hospital.

Methods
-------

### Determination of intestinal flora

A total of 1.5 g of fresh excreta was collected from all subjects, and the log value of the colony forming unit in wet weight per gram of excreta (log CFU/g) was used for the viable count of intestinal beneficial bacteria, such as *Bifidobacterium* and *Lactobacillus*, and pathogenic bacteria, such as *Enterobacter* and *Enterococcus*. The ratio of *Bifidobacterium* to *Enterobacter* (B/E value) was calculated to indicate the index of intestinal colonization resistance, thus evaluating the changes in intestinal flora of subjects.

### Determination of relative expression levels of IL-10 mRNA and IL-17 mRNA in peripheral blood mononuclear cells

A total of 5 ml of fasting venous blood was collected from the subjects, and the changes in relative expression levels of IL-10 mRNA and IL-17 mRNA in the peripheral blood mononuclear cells were detected via reverse transcription-polymerase chain reaction (RT-PCR).

### Determination of serum IL-10 and IL-17 levels

The serum IL-10 and IL-17 levels in subjects were detected via ELISA.

### Statistical analysis

The SPSS 20.0 (IBM Corp., New York, NY, USA) statistical software was used for analysis. Measurement data were presented as mean ± standard deviation, and the Chi-square test was used for measurement data. Paired samples t-test was used for enumeration data, and the Pearson\'s correlation analysis was used for the correlation analysis. P\<0.05 is considered to indicate a statistically significant difference.

Results
=======

### Comparisons of intestinal flora amount and B/E value between the two groups

The number of beneficial bacteria, such as *Bifidobacterium* and *Lactobacillus*, in patient group was significantly lower than in the control group (P\<0.05). The number of pathogenic bacteria, such as Enterobacteriaceae and *Enterococcus*, in the patient group was significantly higher than that in the control group (P\<0.05), and the B/E value in the patient group was significantly lower than in the control group (P\<0.05) ([Table I](#tI-etm-0-0-5490){ref-type="table"}).

### Comparisons of relative expression levels of IL-10 mRNA and IL-17 mRNA between the two groups

The relative expression levels of IL-10 mRNA and IL-17 mRNA in the patient groups were significantly higher than those in control group (P\<0.05) ([Table II](#tII-etm-0-0-5490){ref-type="table"}; [Figs. 1](#f1-etm-0-0-5490){ref-type="fig"} and [2](#f2-etm-0-0-5490){ref-type="fig"}).

### Comparison of serum IL-10 and IL-17 levels between the two groups

The serum IL-10 levels in the patients group were 1.17±0.15 pg/ml, which was significantly higher than that in control group at 0.32±0.04 pg/ml (P\<0.05). The serum IL-17 level in the patient group was 0.96±0.11 pg/ml, which was significantly higher than that in the control group (0.28±0.01 pg/ml) (P\<0.05) ([Table III](#tIII-etm-0-0-5490){ref-type="table"}).

### Analysis of correlation between changes in intestinal flora and serum IL-10 and IL-17 in the patient group

The Pearson\'s correlation analysis shows that the B/E value representing the changes in intestinal flora in the patient group were negatively correlated to serum IL-10 (r=−0.546, P\<0.05), and also negatively correlated with serum IL-17 (r=−0.535, P\<0.05) ([Figs. 3](#f3-etm-0-0-5490){ref-type="fig"} and [4](#f4-etm-0-0-5490){ref-type="fig"}).

Discussion
==========

Intestinal flora in the human body comprise a complex micro-ecosystem composed of probiotics and pathogens. In this micro-ecosystem, the beneficial bacteria and pathogenic bacteria combine in accordance to a certain proportion, and they are extremely important in digestion and absorption within the human body via mutual regulation ([@b7-etm-0-0-5490]--[@b9-etm-0-0-5490]). Research shows that ([@b10-etm-0-0-5490]) the development and progression of liver diseases are closely related to the intestinal microbiology. It has also been reported that ([@b11-etm-0-0-5490],[@b12-etm-0-0-5490]) intestinal probiotics can reduce oxidative stress and inflammatory injury in the liver, which plays a very important roles in the prevention of nonalcoholic fatty liver diseases. The B/E value can generally be used to assess the changes in intestinal flora. This study shows that the number of beneficial bacteria, such as *Bifidobacterium* and *Lactobacillus*, in the patient group was significantly lower than in the control group (P\<0.05). On the other hand, the number of pathogenic bacteria, such as Enterobacteriaceae and *Enterococcus*, in the patient group was significantly higher than that in control group (P\<0.05). The B/E value in the patient group was significantly lower than that in control group (P\<0.05), which suggests that the imbalance of intestinal flora exists in nonalcoholic steatohepatitis, and leads to the injury of intestinal colonization resistance.

Studies have suggested that ([@b5-etm-0-0-5490],[@b13-etm-0-0-5490]) the pathogenesis of nonalcoholic fatty liver disease may be associated with oxidative stress, inflammatory response and other factors. Oxidative stress generally promotes the inflammatory response and releases a variety of inflammatory factors, such as IL-10 and IL-17 ([@b14-etm-0-0-5490]--[@b17-etm-0-0-5490]). This study demonstrates that the relative expression levels of IL-10 and IL-17 mRNA in the patient group were significantly higher than those in the control group (P\<0.05). The serum IL-10 levels in patient group were 1.17±0.15 pg/ml, which was significantly higher than that in the control group at 0.32±0.04 pg/ml (P\<0.05). Furthermore, the serum IL-17 levels in the patient group was 0.96±0.11 pg/ml, which was significantly higher than that in the control group (0.28±0.01 pg/ml) (P\<0.05), which suggests that the increased IL-10 and IL-17 levels are closely related to the development and progression of nonalcoholic steatohepatitis and can reflect the severity of nonalcoholic steatohepatitis.

Due to the close correlation between the changes in intestinal flora, inflammatory factors and the incidence of nonalcoholic steatohepatitis, the B/E value was used to reflect the changes in the intestinal flora, and the correlation analysis was performed for IL-10 and IL-17 in order to provide a related basis for the pathogenesis of nonalcoholic steatohepatitis. The results of this study show that the B/E value in the patient group was negatively correlated with serum IL-10 (r=−0.546, P\<0.05), and also negatively correlated with serum IL-17 (r=−0.535, P\<0.05), which suggests that the imbalance of intestinal flora is related to the damage extent of intestinal colonization resistance and changes in the levels of inflammatory factors, IL-10 and IL-17. It is speculated that the hepatic pathological changes, the imbalance of intestinal flora and the release of inflammatory factors may occur in nonalcoholic steatohepatitis, thus promoting liver injury in the human body ([@b3-etm-0-0-5490],[@b18-etm-0-0-5490]).

In conclusion, IL-10 and IL-17 are highly expressed in the peripheral blood of patients with nonalcoholic steatohepatitis compared to healthy people. The changes in intestinal flora in patients with nonalcoholic steatohepatitis are closely related to the changes in serum IL-10 and IL-17 levels, and they interact and actively participate in the development and progression of nonalcoholic steatohepatitis.

![IL-10 mRNA expression in peripheral blood mononuclear cells. M, marker; IL, interleukin.](etm-15-01-0723-g00){#f1-etm-0-0-5490}

![IL-17 mRNA expression in peripheral blood mononuclear cells. M, marker; IL, interleukin.](etm-15-01-0723-g01){#f2-etm-0-0-5490}

![Correlation between B/E value and serum IL-10. B/E, *Bifidobacterium* to *Enterobacter*; IL, interleukin.](etm-15-01-0723-g02){#f3-etm-0-0-5490}

![Correlation between B/E value and serum IL-17. B/E, *Bifidobacterium* to *Enterobacter*; IL, interleukin.](etm-15-01-0723-g03){#f4-etm-0-0-5490}

###### 

Comparison of intestinal flora amount and B/E value between the two groups (log CFU/g).

  Groups    n    *Bifidobacterium*   *Lactobacillus*   *Enterobacteriaceae*   *Enterococcus*   B/E value
  --------- ---- ------------------- ----------------- ---------------------- ---------------- -----------
  Patient   90   8.56±0.34           9.07±0.02         9.88±0.42              8.02±0.25        0.87±0.03
  Control   80   9.68±0.55           9.84±0.36         8.63±0.17              7.35±0.14        1.04±0.05
  t-test         9.561               10.942            7.338                  8.796            9.005
  P-value        \<0.05              \<0.05            \<0.05                 \<0.05           \<0.05

B/E, *Bifidobacterium* to *Enterobacter*.

###### 

Comparisons of relative expression levels of IL-10 mRNA and IL-17 mRNA between the two groups (mean ± standard deviation).

  Groups    n    IL-10 mRNA   IL-17 mRNA
  --------- ---- ------------ ------------
  Patient   90   0.67±0.06    0.62±0.04
  Control   80   0.18±0.03    0.16±0.02
  t-test         9.116        9.832
  P-value        \<0.05       \<0.05

IL, interleukin.

###### 

Comparison of serum IL-10 and IL-17 levels between the two groups (mean ± standard deviation, pg/ml).

  Groups    n    IL-10       IL-17
  --------- ---- ----------- -----------
  Patient   90   1.17±0.15   0.96±0.11
  Control   80   0.32±0.04   0.28±0.01
  t-test         8.042       9.735
  P-value        \<0.05      \<0.05

IL, interleukin.
